Why Treating Sleep Apnea with CPAP Matters for Seniors

Sleep apnea is one of the most underdiagnosed health conditions affecting older adults. Research estimates that between 30 and 80 percent of adults over 65 have some form of obstructive sleep apnea (OSA) — yet the vast majority remain undiagnosed and untreated. The consequences of leaving sleep apnea unaddressed are serious and well-documented.

CPAP Users Live Longer

A comprehensive meta-analysis published in The Lancet Respiratory Medicine in early 2025, analyzing data from over one million sleep apnea patients worldwide, found that people with obstructive sleep apnea who use CPAP therapy have a 37 percent lower risk of dying from any cause compared to those who go untreated. This represents the strongest evidence to date about CPAP’s impact on longevity and was described by researchers as a wake-up call for anyone with diagnosed sleep apnea who is not compliant with therapy.

Protecting Cognitive Function and Memory

One of the most concerning recent discoveries is the link between untreated sleep apnea and cognitive decline. A 10-year study published in the Journal of Clinical Sleep Medicine — the PROOF study — followed 126 patients aged 65 and older with severe OSA. Those who received CPAP treatment showed statistically significant improvements in mental agility and memory performance at the 10-year mark, while untreated patients declined. Research published in 2025 has also found that the same abnormal protein that damages brains in Alzheimer’s disease appears in the brains of people with untreated sleep apnea.

The American Academy of Sleep Medicine has highlighted CPAP’s role in improving cognitive function, with research showing users demonstrating sharper memory after six months of consistent use.

Cardiovascular Benefits

The Cleveland Clinic notes that consistent CPAP use is associated with improved blood pressure and a reduced risk of cardiovascular disease events including heart attack and stroke. Untreated sleep apnea is linked to high blood pressure, heart disease, Type 2 diabetes, and cognitive impairment. A meta-analysis published in the Journal of Clinical Sleep Medicine found that CPAP treatment was associated with a statistically significant reduction in major adverse cardiovascular events — particularly among patients with high-risk markers of severe OSA.

Immediate Quality-of-Life Benefits

Beyond the long-term protective effects, CPAP therapy produces rapid improvements in daily life. Users consistently report improved sleep quality, dramatically reduced snoring, less daytime sleepiness, and improved mood — often within the first few weeks of consistent use. For seniors who have been fatigued and groggy for years from undiagnosed sleep apnea, the effect of properly treated sleep can feel genuinely transformative.

Sources: The Lancet Respiratory Medicine (2025), Journal of Clinical Sleep Medicine / PROOF Study (PMC4410925), Cleveland Clinic CPAP Guide (2024), American Academy of Sleep Medicine, Journal of Clinical Sleep Medicine Meta-Analysis on CPAP and Cardiovascular Events, Mass General Brigham Research (European Heart Journal).